Literature DB >> 23598521

Reimbursement for thrombectomy devices in patients who are ineligible for intravenous tissue-type plasminogen activator.

Joseph P Broderick1, Thomas A Tomsick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23598521     DOI: 10.1161/STROKEAHA.113.001442

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  3 in total

1.  Characterization of an Intracellular Alkaline Serine Protease from Bacillus velezensis SW5 with Fibrinolytic Activity.

Authors:  Haining Yang; Yang Liu; Yuchang Ning; Changyu Wang; Xin Zhang; Peifang Weng; Zufang Wu
Journal:  Curr Microbiol       Date:  2020-04-09       Impact factor: 2.188

2.  Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices.

Authors:  Jeffrey L Saver; Tudor G Jovin; Wade S Smith; Gregory W Albers; Jean-Claude Baron; Johannes Boltze; Joseph P Broderick; Lisa A Davis; Andrew M Demchuk; Salvatore DeSena; Jens Fiehler; Philip B Gorelick; Werner Hacke; Bill Holt; Reza Jahan; Hui Jing; Pooja Khatri; Chelsea S Kidwell; Kennedy R Lees; Michael H Lev; David S Liebeskind; Marie Luby; Patrick Lyden; J Thomas Megerian; J Mocco; Keith W Muir; Howard A Rowley; Richard M Ruedy; Sean I Savitz; Vitas J Sipelis; Samuel K Shimp; Lawrence R Wechsler; Max Wintermark; Ona Wu; Dileep R Yavagal; Albert J Yoo
Journal:  Stroke       Date:  2013-11-05       Impact factor: 7.914

3.  Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project.

Authors:  Brijesh P Mehta; Thabele M Leslie-Mazwi; Ronil V Chandra; Donnie L Bell; Chung-Huan J Sun; Joshua A Hirsch; James D Rabinov; Natalia S Rost; Lee H Schwamm; Joshua N Goldstein; Wilton C Levine; Rishi Gupta; Albert J Yoo
Journal:  J Am Heart Assoc       Date:  2014-11-11       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.